These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6123577)

  • 21. Structure activity relationship studies with hypothalamic peptide hormones. I. Effect of melanotropin release inhibiting factor and analogs on tolerance to morphine in the rat.
    Bhargava HN; Kim HS
    J Pharmacol Exp Ther; 1982 Feb; 220(2):394-8. PubMed ID: 6120229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Participation of the ventral root in drug-induced tremor (tremorine).
    Forcier P; Tasker RR
    J Neurosurg; 1969 Jan; 30(1):30-4. PubMed ID: 5766612
    [No Abstract]   [Full Text] [Related]  

  • 23. New evidence that demonstrates that L-pro-L-leu-L-gly-NH2 might be the natural MIF.
    Vivas A; Celis ME
    Acta Physiol Lat Am; 1977; 27(4):177-82. PubMed ID: 31762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pharmacological study of amantadine, a new antiparkinson drug].
    Mori J; Sato Y; Oashi T; Hitomi M
    Nihon Yakurigaku Zasshi; 1974 Jan; 70(1):119-26. PubMed ID: 4858046
    [No Abstract]   [Full Text] [Related]  

  • 25. Depression by amantadine of drug-induced rigidity in the rat.
    Jurna I; Grossmann W; Nell T
    Neuropharmacology; 1972 Jul; 11(4):559-64. PubMed ID: 5047944
    [No Abstract]   [Full Text] [Related]  

  • 26. Synthesis of Pro-Leu-Gly-NH2 analogues modified at the prolyl residue and evaluation of their effects on the receptor binding activity of the central dopamine receptor agonist, ADTN.
    Johnson RL; Rajakumar G; Yu KL; Mishra RK
    J Med Chem; 1986 Oct; 29(10):2104-7. PubMed ID: 2876104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Separation of the tremorous and muscular rigidity components of the ethanol withdrawal syndrome in the rat.
    Derr RF; Derr MI
    Physiol Behav; 1986; 38(1):1-3. PubMed ID: 3786490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The cholinergic rigidity.
    Jurna I
    Pharmacol Ther B; 1976; 2(2):413-21. PubMed ID: 785492
    [No Abstract]   [Full Text] [Related]  

  • 29. Tremorine-oxotremorine-induced tremor, hypothermia and analgesia, and physostigmine toxicity, in mice after pretreatment with beta-adrenoceptor antagonists.
    Barar FS; Madan BR
    J Pharm Pharmacol; 1976 Apr; 28(4):286-9. PubMed ID: 6716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathophysiology of parkinsonian motor abnormalities.
    Wichmann T; DeLong MR
    Adv Neurol; 1993; 60():53-61. PubMed ID: 8420185
    [No Abstract]   [Full Text] [Related]  

  • 31. The role of adrenergic mechanism in tremorine-induced tremors in rats: antitremor effect of beta-adrenoceptor antagonists.
    Paul V
    Indian J Physiol Pharmacol; 1986; 30(4):307-12. PubMed ID: 2883120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. L-dopa potentiating analogs of Pro-Leu-Gly-NH2 with oral efficacy.
    Albrecht HP; Hofman HP; Klebe G; Kreiskott H
    Boll Chim Farm; 1991 Feb; 130(2):55-9. PubMed ID: 1678611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GABAergic, dopaminergic and cholinergic interaction in tremorine-induced tremors in mice.
    Shukla VK; Garg SK; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 1988 Jan; 10(1):27-31. PubMed ID: 2895827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Raclopride and chlorpromazine, but not clozapine, increase muscle rigidity in the rat: relationship with D2 dopamine receptor occupancy.
    Hemsley KM; Crocker AD
    Neuropsychopharmacology; 1999 Jul; 21(1):101-9. PubMed ID: 10379524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The physiology of tremorine-induced tremor.
    Tasker RR; Kertesz A
    J Neurosurg; 1965 May; 22(5):449-57. PubMed ID: 5825607
    [No Abstract]   [Full Text] [Related]  

  • 36. Tremor induced by tremorine and its antagonism by anti-Parkinson drugs.
    EVERETT GM; BLOCKUS LE; SHEPPERD IM
    Science; 1956 Jul; 124(3211):79. PubMed ID: 13337354
    [No Abstract]   [Full Text] [Related]  

  • 37. Antiparkinsonian-like effects of Plumbago scandens on tremorine-induced tremors methodology.
    Morais LC; Quintans-Júnior LJ; Franco CI; Almeida JR; Almeida RN
    Pharmacol Biochem Behav; 2004 Dec; 79(4):745-9. PubMed ID: 15582683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic effect of SCH 58261, an adenosine A2A receptor antagonist, and L-DOPA on the reserpine-induced muscle rigidity in rats.
    Wardas J
    Pol J Pharmacol; 2003; 55(2):155-64. PubMed ID: 12926542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biomechanical and electromyogram characterization of neuroleptic-induced rigidity in the rat.
    Wu YN; Hyland BI; Chen JJ
    Neuroscience; 2007 Jun; 147(1):183-96. PubMed ID: 17507166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modification of drug-induced catatonia and tremors by quapazine in rats and mice.
    Kulkarni SK; Arzi A; Kaul PN
    Jpn J Pharmacol; 1980 Apr; 30(2):129-35. PubMed ID: 7192759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.